Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,857 | -5,255 | -8,621 | -6,895 | N/A |
| Depreciation Amortization | 11 | 12 | 22 | 22 | N/A |
| Other Working Capital | -40 | -130 | -969 | 1,237 | N/A |
| Other Operating Activity | -849 | 514 | 3,266 | 1,911 | 0 |
| Operating Cash Flow | $-4,735 | $-4,859 | $-6,302 | $-3,725 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -529 | -272 | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | -6 | N/A |
| Other Investing Activity | -14 | 34 | -26 | 0 | 0 |
| Investing Cash Flow | $-542 | $-238 | $-26 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,250 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 415 | 6,297 | 11,705 | 583 | N/A |
| Other Financing Activity | -43 | -43 | -41 | -71 | 0 |
| Financing Cash Flow | $2,623 | $6,254 | $11,664 | $512 | $N/A |
| Exchange Rate Effect | 3 | -12 | -38 | -23 | N/A |
| Beginning Cash Position | 6,574 | 5,428 | 129 | 3,370 | N/A |
| End Cash Position | 3,923 | 6,574 | 5,428 | 129 | N/A |
| Net Cash Flow | $-2,651 | $1,146 | $5,299 | $-3,241 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,735 | -4,859 | -6,302 | -3,725 | N/A |
| Capital Expenditure | N/A | N/A | N/A | -6 | N/A |
| Free Cash Flow | -4,735 | -4,859 | -6,302 | -3,730 | 0 |